GSK Clinical Trials Call Center

San Francisco, California 94115

0 studies enrolling now · 3 studies all time

What they study most

HIV Infections, Hormone-receptor Positive Breast Cancer

Studies at this site

• Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer — Withdrawn before enrolling
• A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients — Completed
• Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults — Completed